Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases (Q45484175)

14 December 2017

Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases (English)

1 reference

14 December 2017

1 reference

1

Darwin J Operario

1 reference

14 December 2017

Holly M Reynolds

2

1 reference

PubMed ID

15823610

14 December 2017

Baek Kim

series ordinal

3

1 reference

PubMed ID

15823610

14 December 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

14 December 2017

1 reference

14 December 2017

335

1 reference

14 December 2017

1

1 reference

14 December 2017

106-121

1 reference

Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

The processivity and fidelity of DNA synthesis exhibited by the reverse transcriptase of bovine leukemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Fidelity of the RNA-dependent DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency virus types 1 and 2 and of murine leukemia virus: mispair extension frequencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Analyzing fidelity of DNA polymerases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Coupling ribose selection to fidelity of DNA synthesis. The role of Tyr-115 of human immunodeficiency virus type 1 reverse transcriptase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Comparative kinetic analyses of interaction of inhibitors with Rauscher murine leukemia virus and human immunodeficiency virus reverse transcriptases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Elucidation of the role of Arg 110 of murine leukemia virus reverse transcriptase in the catalytic mechanism: biochemical characterization of its mutant enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Gel kinetic analysis of DNA polymerase fidelity in the presence of proofreading using bacteriophage T4 DNA polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Inhibition of reverse transcriptase from feline immunodeficiency virus by analogs of 2'-deoxyadenosine-5'-triphosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Identification of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Mechanistic Understanding of an Altered Fidelity Simian Immunodeficiency Virus Reverse Transcriptase Mutation, V148I, Identified in a Pig-tailed Macaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Differential effects of transforming avian RNA tumor viruses on avian macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

The role of phenylalanine-119 of the reverse transcriptase of mouse mammary tumour virus in DNA synthesis, ribose selection and drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Analysis of nucleotide insertion and extension at 8-oxo-7,8-dihydroguanine by replicative T7 polymerase exo- and human immunodeficiency virus-1 reverse transcriptase using steady-state and pre-steady-state kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Transduction of terminally differentiated neurons by avian sarcoma virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Infection of nondividing cells by Rous sarcoma virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Transduction of interphase cells by avian sarcoma virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Role of glutamine-151 of human immunodeficiency virus type-1 reverse transcriptase in RNA-directed DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Valine of the YVDD motif of moloney murine leukemia virus reverse transcriptase: role in the fidelity of DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Genetic selection in Escherichia coli for active human immunodeficiency virus reverse transcriptase mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

New human immunodeficiency virus, type 1 reverse transcriptase (HIV-1 RT) mutants with increased fidelity of DNA synthesis. Accuracy, template binding, and processivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Human immunodeficiency virus infection of cells arrested in the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Thermal effects on reverse transcription: improvement of accuracy and processivity in cDNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Influence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Pre- and postexposure chemoprophylaxis: evidence that 3'-azido-3'-dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

The impact of the M184V substitution in HIV-1 reverse transcriptase on treatment response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Differential antiviral activities and intracellular metabolism of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Expression of reverse transcriptase from feline immunodeficiency virus in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Catalytic features of the recombinant reverse transcriptase of bovine leukemia virus expressed in bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Enhanced impairment of chain elongation by inhibitors of HIV reverse transcriptase in cell-free reactions yielding longer DNA products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Biochemical and immunological properties of the DNA polymerase and RNAase H activities of purified feline leukemia virus reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Lysine 152 of MuLV reverse transcriptase is required for the integrity of the active site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Role of Q190 of MuLV RT in ddNTP resistance and fidelity of DNA synthesis: a molecular model of interactions with substrates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Mechanistic differences in RNA-dependent DNA polymerization and fidelity between murine leukemia virus and HIV-1 reverse transcriptases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Nucleotide sequence and genomic organization of feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

DNA synthesis exhibited by the reverse transcriptase of mouse mammary tumor virus: processivity and fidelity of misinsertion and mispair extension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Physiological concentrations of purines and pyrimidines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Functional analysis of HIV-1 reverse transcriptase motif C: site-directed mutagenesis and metal cation interaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

7 January 2021

Death and the retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Molecular architecture of the mutagenic active site of human immunodeficiency virus type 1 reverse transcriptase: roles of the beta 8-alpha E loop in fidelity, processivity, and substrate interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Mechanistic role of residue Gln151 in error prone DNA synthesis by human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT). Pre-steady state kinetic study of the Q151N HIV-1 RT mutant with increased fidelity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Effect of the O6 substituent on misincorporation kinetics catalyzed by DNA polymerases at O(6)-methylguanine and O(6)-benzylguanine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

Suppression of multiplication of avian sarcoma virus by rapid spread of transformation-defective virus of the same subgroup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

7 January 2021

Purification and characterization of the DNA polymerase and RNase H activities in Moloney murine sarcoma-leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

7 January 2021

Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

7 January 2021

Cloning and expression of a human T-lymphotropic virus type 1 protein with reverse transcriptase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

7 January 2021

Comparison of two host cell range variants of feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

7 January 2021

A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

7 January 2021

Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

7 January 2021

Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.010

7 January 2021

10.1016/J.VIROL.2005.02.010

Identifiers

DOI

1 reference

14 December 2017

1 reference

PubMed ID

15823610